|
|
|
|
|
by jbritton
2128 days ago
|
|
To my knowledge there has not yet been a trial completed with HCQ+Zinc. There are several doctors stating positive observational results with HCQ+Zinc.
Iām waiting for this study to complete:
https://clinicaltrials.gov/ct2/show/NCT04370782 Zinc has antiviral properties. It has been shown to stop Sars Cov2 replication in-vitro.
Cells limit their Zinc intake.
HCQ facilitates Zinc getting into cells. |
|
So I'll see, for example, some otherwise-highly-credible UCSF researchers mention a bunch of evidence they think puts the potential of HCQ to help to rest, without any mention of Zinc considerations (even in passing, or to ridicule, or to share why they don't think the link credible). But even coincident upon the very 1st discussions of HCQ as having potential, Derek Lowe shared an anecdote about how carrying-Zinc seemed essential to Chloroquine-related-compoounds' bioactivity (https://blogs.sciencemag.org/pipeline/archives/2020/03/20/ch...).
And, in many parts of the world, HCQ ā as a cheap drug that, in moderate doses with proper monitoring, is very low-risk ā is already considered part of the Covid-19 "standard-of-care". So, it's given even to the 'control' arms of trials for other compounds ā making both its effects, and those other compounds' effects, harder to disentangle.
All I want now is true randomized trials - and can't at least one of those monitor, or vary the supplementation of, Zinc as well?